As Chief Executive Officer of Slade Health and Slade Pharmacy, Russell leads all aspects of compounding, pharmacy and retail operations. His leadership is defined by a strong focus on clinical excellence, innovation and patient-centred care.
Russell has worked in senior management roles across both public and private sectors in Australia and the United Kingdom. He is a former Board Director of the Pharmaceutical Society of Australia (PSA) and served as Chair of the Advanced Pharmacy Australia (AdPha) Leadership and Management Committee. He holds a Bachelor of Pharmacy and postgraduate qualifications in clinical pharmacy and management (MBA) from Curtin University and Nottingham University Business School.
Since joining Icon Group, Russell has held numerous leadership roles, including Director of the Pharmacy Practice Unit, General Manager of Pharmacy Services in Western Australia, and State Manager (WA & SA) for Icon Cancer Centre. His wide-ranging experience across cancer care and pharmacy provides a comprehensive perspective on operations and multidisciplinary clinical quality.
Appointed CEO in 2025, Russell has overseen digital transformation, commercial excellence, and sustainable growth across Slade’s compounding and pharmacy services. He is a hands-on leader committed to expanding opportunities for compounding and pharmacy professionals, supporting workforce development, and ensuring patients and hospital partners continue to receive the highest-quality care.